Rajan Giri

429 total citations
10 papers, 332 citations indexed

About

Rajan Giri is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Rajan Giri has authored 10 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Rajan Giri's work include Synthesis and Characterization of Heterocyclic Compounds (3 papers), Receptor Mechanisms and Signaling (3 papers) and Quinazolinone synthesis and applications (3 papers). Rajan Giri is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (3 papers), Receptor Mechanisms and Signaling (3 papers) and Quinazolinone synthesis and applications (3 papers). Rajan Giri collaborates with scholars based in United States and India. Rajan Giri's co-authors include Tony Giordano, Kamala K. Vasu, Jill M. Williams, Adam R. Benoit, David M. Ferguson, Harneet Kaur, Hiroshi Hiasa, John R. Goodell, V. Sudarsanam and Bing Chen and has published in prestigious journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Chemico-Biological Interactions.

In The Last Decade

Rajan Giri

9 papers receiving 319 citations

Peers

Countries citing papers authored by Rajan Giri

Since Specialization

Citations

This map shows the geographic impact of Rajan Giri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajan Giri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajan Giri more than expected).

Fields of papers citing papers by Rajan Giri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajan Giri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajan Giri. The network helps show where Rajan Giri may publish in the future.

Co-authorship network of co-authors of Rajan Giri

This figure shows the co-authorship network connecting the top 25 collaborators of Rajan Giri. A scholar is included among the top collaborators of Rajan Giri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajan Giri. Rajan Giri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Further studies on C2′-substituted 1-phenylbenzazepines as dopamine D1 receptor ligands 2022 ·Bioorganic Chemistry ·Rajan Giri, Namballa Hari Krishna, (unknown), Ian L. Alberts, Wayne W. Harding	1
2	Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines 2020 ·Bioorganic & Medicinal Chemistry Letters ·Rajan Giri, Namballa Hari Krishna, (unknown), Ian L. Alberts, Wayne W. Harding	4
3	Synthesis, pharmacological evaluations, and molecular docking studies on a new 1,3,4,11b‐tetrahydro‐1H‐fluoreno[9,1‐cd]azepine framework: Rigidification of D₁ receptor selective 1‐phenylbenzazepines and discovery of a new 5‐HT₆ receptor scaffold 2020 ·Chemical Biology & Drug Design ·Rajan Giri, Ian L. Alberts, Wayne W. Harding	1
4	Diverse Approaches and Recent Advances in the Synthesis of Tetrahydroprotoberberines 2018 ·Current Organic Chemistry ·(unknown), Rajan Giri, (unknown), (unknown), Wayne W. Harding	2
5	9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant glioma 2012 ·Cancer Chemotherapy and Pharmacology ·Aaron M. Teitelbaum, Jose L. Gallardo, (unknown), Rajan Giri, Adam R. Benoit, Michael R. Olin, (unknown), John R. Ohlfest, Rory P. Remmel, David M. Ferguson	10
6	Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-кB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents 2010 ·Bioorganic & Medicinal Chemistry ·Rajan Giri, (unknown), Tony Giordano, Jill M. Williams, (unknown), Kamala K. Vasu, V. Sudarsanam	40
7	Synthesis and cancer cell cytotoxicity of substituted xanthenes 2010 ·Bioorganic & Medicinal Chemistry ·Rajan Giri, John R. Goodell, (unknown), Adam R. Benoit, Harneet Kaur, Hiroshi Hiasa, David M. Ferguson	88
8	Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-κB, AP-1 mediated transcription and eIF-4E mediated translational activation: Inhibitors of multi-pathways involve in cancer 2010 ·European Journal of Medicinal Chemistry ·Rajan Giri, (unknown), Tony Giordano, Bing Chen, (unknown), Kamala K. Vasu, V. Sudarsanam	29
9	Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents 2008 ·European Journal of Medicinal Chemistry ·Rajan Giri, (unknown), Tony Giordano, Jill M. Williams, (unknown), (unknown), Kamala K. Vasu	146
10	Chloro acridone derivatives as cytotoxic agents active on multidrug-resistant cell lines and their duplex DNA complex studies by electrospray ionization mass spectrometry 2008 ·Chemico-Biological Interactions ·(unknown), (unknown), Rajan Giri, (unknown), (unknown), (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact